All Stories

  1. A Multinational Observational Study Exploring Adherence With the Kidney Disease
  2. Protocol and statistical analysis plan for the REstricted fluid therapy VERsus Standard trEatment in Acute Kidney Injury—REVERSE‐AKI randomized controlled pilot trial
  3. Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study
  4. Net Ultrafiltration Prescription and Practice Among Critically Ill Patients Receiving Renal Replacement Therapy
  5. Lung–kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup
  6. Report of the first AKI Round Table meeting: an initiative of the ESICM AKI Section
  7. Saturable elimination of piperacillin in critically ill patients: implications for continuous infusion
  8. Evaluation of the quality of the communication and emotional support during the donation procedure: The use of the donor family questionnaire (DFQ)
  9. Contrast-associated acute kidney injury: does it really exist, and if so, what to do about it?
  10. Cytokine removal in human septic shock: Where are we and where are we going?
  11. Adherence to guidelines for the management of donors after brain death
  12. Model for end-stage liver disease score and hemodynamic instability as a predictor of poor outcome in early transjugular intrahepatic portosystemic shunt treatment for acute variceal hemorrhage
  13. Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury
  14. Plasma neutrophil gelatinase-associated lipocalin (NGAL) for timing of initiation of renal replacement therapy for acute kidney injury?
  15. Paving the way for precision medicine v2.0 in intensive care by profiling necroinflammation in biofluids
  16. Global epidemiology and outcomes of acute kidney injury
  17. Update on Perioperative Acute Kidney Injury
  18. Development of key interventions and quality indicators for the management of an adult potential donor after brain death: a RAND modified Delphi approach
  19. Angiotensin inhibition in patients with acute kidney injury: Dr. Jekyll or Mr. Hyde?
  20. Kinetics of Urinary Cell Cycle Arrest Markers for Acute Kidney Injury Following Exposure to Potential Renal Insults
  21. Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP)
  22. Low flow extracorporeal CO2 removal in ARDS patients: a prospective short-term crossover pilot study
  23. Brief Orals
  24. Epidemiology of cardiac surgery-associated acute kidney injury
  25. Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017
  26. Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference
  27. Diagnostic work-up and specific causes of acute kidney injury
  28. Recovery after Acute Kidney Injury
  29. Current state of the art for renal replacement therapy in critically ill patients with acute kidney injury
  30. Diagnosis of cardiac surgery-associated acute kidney injury: differential roles of creatinine, chitinase 3-like protein 1 and neutrophil gelatinase-associated lipocalin: a prospective cohort study
  31. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
  32. The intensive care medicine agenda on acute kidney injury
  33. Assessment of the Optimal Operating Parameters during Extracorporeal CO2 Removal with the Abylcap® System
  34. Diagnosis of cardiac surgery-associated acute kidney injury from functional to damage biomarkers
  35. Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical applications
  36. Nomenclature for renal replacement therapy in acute kidney injury: basic principles
  37. Defining the characteristics and expectations of fluid bolus therapy: A worldwide perspective
  38. Understanding oliguria in the critically ill
  39. Long-term outcome in ICU patients with acute kidney injury treated with renal replacement therapy: a prospective cohort study
  40. Recommendations for further improvement of the deceased organ donation process in Belgium
  41. Care pathways for organ donation after brain death: guidance from available literature?
  42. Zero deaths from AKI by 2025: focus on awareness and therapy
  43. The perceived quality of interprofessional teamwork in an intensive care unit: A single centre intervention study
  44. Applications for Detection of Acute Kidney Injury Using Electronic Medical Records and Clinical Information Systems: Workgroup Statements from the 15th ADQI Consensus Conference
  45. Impact of Electronic-Alerting of Acute Kidney Injury: Workgroup Statements from the 15th ADQI Consensus Conference
  46. Urinary chitinase 3-like protein 1 for early diagnosis of acute kidney injury: a prospective cohort study in adult critically ill patients
  47. How to Solve the Underestimated Problem of Overestimated Sodium Results in the Hypoproteinemic Patient
  48. Treating Acute Kidney Injury. One Less Weapon in the Armamentarium?
  49. Precision Fluid Management in Continuous Renal Replacement Therapy
  50. Acute Kidney Injury in Cardiorenal Syndrome Type 1 Patients: A Systematic Review and Meta-Analysis
  51. Preoperative abnormalities in serum sodium concentrations are associated with higher in-hospital mortality in patients undergoing major surgery
  52. Faculty of 1000 evaluation for The Effects of Alternative Resuscitation Strategies on Acute Kidney Injury in Patients with Septic Shock.
  53. Long-term quality of life in critically ill patients with acute kidney injury treated with renal replacement therapy: a matched cohort study
  54. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study
  55. Fluid challenges in intensive care: the FENICE study
  56. Influence of severity of illness on neutrophil gelatinase-associated lipocalin performance as a marker of acute kidney injury: a prospective cohort study of patients with sepsis
  57. Comparison of different equations to assess glomerular filtration in critically ill patients
  58. Variation in Risk and Mortality of Acute Kidney Injury in Critically Ill Patients: A Multicenter Study
  59. Tissue Inhibitor Metalloproteinase-2 (TIMP-2)*IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI
  60. Contrast-associated AKI in the critically ill
  61. Acute kidney injury survivors should have long-term follow-up
  62. Belgian Modified Classification of Maastricht for Donors After Circulatory Death
  63. Four phases of intravenous fluid therapy: a conceptual model †
  64. The 12th consensus conference of the Acute Dialysis Quality Initiative (ADQI XII) †
  65. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers
  66. AKI in early sepsis is a continuum from transient AKI without tubular damage over transient AKI with minor tubular damage to intrinsic AKI with severe tubular damage
  67. A Multiscale Entropy-Based Tool for Scoring Severity of Systemic Inflammation*
  68. Severe lactic acidosis in critically ill patients with acute kidney injury treated with renal replacement therapy
  69. How has urinary proteomics contributed to the discovery of early biomarkers of acute kidney injury?
  70. CLINICAL ACUTE KIDNEY INJURY 1
  71. “Piece” of mind: End of life in the intensive care unit Statement of the Belgian Society of Intensive Care Medicine
  72. What’s new in the controversy on the renal/tissue toxicity of starch solutions?
  73. Pathophysiology of the Cardiorenal Syndromes: Executive Summary from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)
  74. Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial
  75. Implementing the Kidney Disease
  76. Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy
  77. A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation*
  78. Factors associated with inadequate early vancomycin levels in critically ill patients treated with continuous infusion
  79. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
  80. Cardiorenal Syndrome Type 3: Pathophysiologic and Epidemiologic Considerations
  81. Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
  82. Pathophysiology of the Cardiorenal Syndromes: Executive Summary from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)
  83. Urinary output and fractional excretion of sodium and urea as indicators of transient versus intrinsic acute kidney injury during early sepsis
  84. Urinary chitinase 3-like 1, a novel biomarker for acute kidney injury in adult cardiac intensive care patients: a pilot study
  85. ESICM 2012 MONDAY SESSIONS 15 October, 2012
  86. Mortality after surgery in Europe: a 7 day cohort study
  87. Renal Physiology in the Critically Ill Obese Patient
  88. Effects of Fractionated Plasma Separation and Adsorption on Survival in Patients With Acute-on-Chronic Liver Failure
  89. Impact of real-time electronic alerting of acute kidney injury on therapeutic intervention and progression of RIFLE class*
  90. Recommendations for the Management of Crush Victims in Mass Disasters
  91. Epidemiology of contrast-associated acute kidney injury in ICU patients: reply to Valette and du Cheyron
  92. Prerenal Azotemia
  93. AKI patients have worse long-term outcomes, especially in the immediate post-ICU period
  94. Contrast Nephropathy
  95. Epidemiology of contrast-associated acute kidney injury in ICU patients: a retrospective cohort analysis
  96. In Reply to ‘Intra-abdominal Pressure Can Be Estimated Inexpensively by the Sagittal Abdominal Diameter'
  97. Serum urea concentration is probably not related to outcome in ICU patients with AKI and renal replacement therapy
  98. Clinical review: Use of renal replacement therapies in special groups of ICU patients
  99. Intra-abdominal Hypertension and Abdominal Compartment Syndrome
  100. Clinical Consequences of Acute Kidney Injury
  101. Morbidity and Mortality of Bloodstream Infections in Patients With Severe Burn Injury
  102. Defining acute kidney injury: playing hide-and-seek with the unknown man?
  103. Application of the RIFLE criteria in patients with crush-related acute kidney injury after mass disasters
  104. Outcome of acute kidney injury in severe burns: a systematic review and meta-analysis
  105. AKI severity class doesn't tell all: the case for transient AKI
  106. Antimicrobial prophylaxis in liver transplant patients – a multicenter survey endorsed by the European Liver and Intestine Transplant Association
  107. A comparison of three methods to estimate baseline creatinine for RIFLE classification
  108. Pro/con debate: Continuous versus intermittent dialysis for acute kidney injury: a never-ending story yet approaching the finish?
  109. ARDS of Early or Late Onset
  110. Acute Kidney Injury in Critically Ill Patients with Cancer
  111. Abdominal decompression for intra-abdominal hypertension after simultaneous pancreas-kidney transplantation
  112. Epidemiology of Acute Kidney Injury
  113. Modern Classification of Acute Kidney Injury
  114. Renal replacement therapy is an independent risk factor for mortality in critically ill patients with acute kidney injury
  115. Severe burn injury in europe: a systematic review of the incidence, etiology, morbidity, and mortality
  116. Thrombocytopenia and outcome in critically ill patients with bloodstream infection
  117. Intensive vs conventional blood glucose control in critically ill patients
  118. How to remove accumulated iodine in burn-injured patients
  119. Prerenal Acute Kidney Failure
  120. Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis
  121. Epidemiology of infection in critically ill patients with acute renal failure
  122. Enterobacteriaceaebacteremia after liver transplantation
  123. Intensive insulin therapy: The swinging pendulum of evidence*
  124. The prevention of acute kidney injury an in-depth narrative review: Part 2: Drugs in the prevention of acute kidney injury
  125. Development and validation of a model for prediction of mortality in patients with acute burn injury
  126. Acute kidney injury in the intensive care unit: It’s the gene, stupid!*
  127. The prevention of acute kidney injury: an in-depth narrative review Part 1: volume resuscitation and avoidance of drug- and nephrotoxin-induced AKI
  128. The value of procalcitonin to diagnose infection in critically ill patient: caveat emptor!
  129. Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial
  130. Impact of local circumstances on outcome of renal casualties in major disasters
  131. Variation in critical care services across North America and Western Europe*
  132. Blood Stream Infections of Abdominal Origin in the Intensive Care Unit: Characteristics and Determinants of Death
  133. Epidemiology of acute kidney injury: How big is the problem?
  134. Timing of Initiation and Discontinuation of Renal Replacement Therapy in AKI: Unanswered Key Questions
  135. Trends in mortality in coronary artery bypass graft patients with acute renal failure
  136. Transvesical intra-abdominal pressure measurement using minimal instillation volumes: how low can we go?
  137. Development of a Clinical Research Agenda for Acute Kidney Injury Using an International, Interdisciplinary, Three-Step Modified Delphi Process
  138. Acute kidney injury in burns: a story of volume and inflammation
  139. Acute kidney injury: Epidemiology and assessment
  140. Service-oriented Subscription Management of Medical Decision Data in the Intensive Care Unit
  141. The Diagnosis of Relative Adrenal Insufficiency: The Long and Winding Road…
  142. Dynamics of C-reactive protein and white blood cell count in critically ill patients with nosocomial Gram positive vs. Gram negative bacteremia: a historical cohort study
  143. Health Implications of Antimicrobial Resistance for Patients With Acute Kidney Injury and Bloodstream Infection
  144. The effect of neuromuscular blockers in patients with intra-abdominal hypertension
  145. Relative adrenal insufficiency in patients with severe acute pancreatitis
  146. Semicontinuous intra-abdominal pressure measurement using an intragastric Compliance catheter
  147. Extrapancreatic Inflammation on Abdominal Computed Tomography as an Early Predictor of Disease Severity in Acute Pancreatitis
  148. The future of surgical critical care: A European perspective
  149. Earthquakes and crush syndrome casualties: Lessons learned from the Kashmir disaster
  150. A novel approach for prediction of tacrolimus blood concentration in liver transplantation patients in the intensive care unit through support vector regression
  151. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
  152. Incidence, Classification, and Outcomes of Acute Kidney Injury
  153. Acute kidney injury: epidemiology and diagnostic criteria
  154. RIFLE criteria provide robust assessment of kidney dysfunction and correlate with hospital mortality*
  155. Effect of fluconazole consumption on long-term trends in candidal ecology
  156. Current pharmacotherapeutic recommendations for acute pancreatitis
  157. Saline volume in transvesical intra-abdominal pressure measurement: enough is enough
  158. Clinical and Economic Outcomes in Critically Ill Patients with Nosocomial Catheter-Related Bloodstream Infections
  159. Outcome and changes over time in survival following severe burns from 1985 to 2004
  160. Would Patients with More Subtle Signs of Coagulopathy Have Benefited from Treatment with Activated Protein C?
  161. Colonization Status and Appropriate Antibiotic Therapy for Nosocomial Bacteremia Caused by Antibiotic-Resistant Gram-Negative Bacteria in an Intensive Care Unit
  162. Influence of Matching for Exposure Time on Estimates of Attributable Mortality Caused by Nosocomial Bacteremia in Critically Ill Patients
  163. Physiologic Consequences of Acute Renal Failure on the Critically Ill
  164. Assessment of renal function in recently admitted critically ill patients with normal serum creatinine
  165. Fluid vs. air for semicontinuous intra-abdominal pressure measurements using a compliance catheter
  166. Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies
  167. Phenytoin intoxication in critically ill patients
  168. Acute Effects of Upright Position on Gas Exchange in Patients With Acute Respiratory Distress Syndrome
  169. Emergence of Antibiotic Resistance in Infected Pancreatic Necrosis
  170. Reflections on the definition, classification, and diagnostic evaluation of acute renal failure
  171. The assumed problem of air bubbles in the tubing during intra-abdominal pressure measurement
  172. Clinical characteristics of patients developing ARF due to sepsis/systemic inflammatory response syndrome: results of a prospective study
  173. Effect of Nosocomial Bloodstream Infection on the Outcome of Critically Ill Patients with Acute Renal Failure Treated with Renal Replacement Therapy
  174. Absence of Excess Mortality in Critically Ill Patients With Nosocomial Escherichia coli Bacteremia
  175. Adrenal Insufficiency in Severe Acute Pancreatitis
  176. Estimates of attributable mortality of systemic candida infection in the ICU
  177. Acute Renal Failure in Patients with Sepsis in a Surgical ICU: Predictive Factors, Incidence, Comorbidity, and Outcome
  178. Is MRSA More Pathogenic in Critically Ill Patients?—Reply
  179. The Effect of Tube Thoracostomy on Oxygenation in ICU Patients
  180. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication*
  181. Reappraisal of attributable mortality in critically ill patients with nosocomial bacteraemia involving Pseudomonas aeruginosa
  182. No early respiratory benefit with CVVHDF in patients with acute renal failure and acute lung injury
  183. Outcome and Attributable Mortality in Critically Ill Patients With Bacteremia Involving Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus
  184. Effects of nosocomial candidemia on outcomes of critically ill patients
  185. Are reduced tacrolimus dosages needed in the early postoperative period following living donor liver transplantation in adults?
  186. Significant increase of activated partial thromboplastin time by heparinization of the radial artery catheter flush solution with a closed arterial catheter system
  187. Carsin H, et al. Cultured epithelial autografts in extensive burn coverage of severely traumatized patients: a five year single-center experience with 30 patients. Burns 2000;26:379–387
  188. Outcome in critically ill patients with candidal fungaemia: Candida albicans vs. Candida glabrata
  189. Staphylococcal septicaemia in burns
  190. Ozumba UC, Jiburum BC. Bacteriology of burn wounds in Enugu, Nigeria. Burns 2000; 26(2): 178–80
  191. Modulation of liver graft hemodynamics by partial ablation of the splenic circuit: a way to increase hepatic artery flow?
  192. Inadequate Proof of Adverse Outcome Due to the Use of Fluconazole in Critically Ill Patients
  193. Antibiotic Resistance and Exposure to Different Generation Cephalosporins
  194. Tracheal Colonization in Pneumonia
  195. Biocompatibility and acute renal failure
  196. Use of continuous bispectral EEG monitoring to assess depth of sedation in ICU patients
  197. Management of Candidal Thrombophlebitis of the Central Veins: Case Report and Review
  198. The Organization of the European Renal Disaster Relief Task Force
  199. Mechanisms of uremic inhibition of phagocyte reactive species production: Characterization of the role of p-cresol
  200. Definition, Classification, and Epidemiology of Acute Kidney Disease